Analysts fell to the sidelines weighing in on Costco (COST – Research Report) and Medifast (MED – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.
Costco (COST)
D.A. Davidson analyst Michael Baker maintained a Hold rating on Costco today. The company’s shares closed last Wednesday at $719.78, close to its 52-week high of $723.32.
According to TipRanks.com, Baker is a 4-star analyst with an average return of
Costco has an analyst consensus of Strong Buy, with a price target consensus of $698.04, implying a -2.3% downside from current levels. In a report issued on February 6, Wells Fargo also maintained a Hold rating on the stock with a $610.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Medifast (MED)
D.A. Davidson analyst Linda Bolton Weiser maintained a Hold rating on Medifast today and set a price target of $67.00. The company’s shares closed last Wednesday at $54.05, close to its 52-week low of $51.44.
According to TipRanks.com, Weiser is a 4-star analyst with an average return of
Currently, the analyst consensus on Medifast is a Hold with an average price target of $67.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on COST:
- Costco Wholesale Corporation Reports January Sales Results
- QQQ ETF Update, 2/7/2024
- Costco price target raised to $750 from $700 at Telsey Advisory
- Costco Wholesale Corporation Announces Richard Galanti Will Step Down as CFO, Names Gary Millerchip New CFO
- Costco announces CFO Galanti to step down, Millerchip new CFO
